Language
English
Publication Date
1-1-2023
Journal
Methods in Molecular Biology
DOI
10.1007/978-1-0716-2760-0_18
PMID
36331776
Abstract
West Nile virus (WNV) can cause severe and sometimes fatal disease, but we do not have treatments or therapeutics to manage these outcomes. Since its introduction to the USA in 1999, WNV has been handled in a biosafety level 3 laboratory to decrease risk to researchers, requiring strict safety protocols and important considerations with planning experiments. Recent changes in US guidelines suggest that WNV can be handled at a lower biosafety level due to its endemicity in the USA and generally minor symptoms, but some research still requires the use of the agent at biosafety level 3. This chapter will briefly discuss the considerations of biosafety when working with WNV.
Keywords
Humans, West Nile virus, West Nile Fever, Containment of Biohazards, Arbovirus, Biosafety, Biosafety level, Risk group, West Nile virus
Published Open-Access
yes
Recommended Citation
Freedom M Green and Shannon E Ronca, "Safety Procedures to Work with West Nile Virus in Biosafety Level 3 Facilities" (2023). Faculty, Staff and Students Publications. 6505.
https://digitalcommons.library.tmc.edu/baylor_docs/6505